BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10265-10272
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10265
Figure 1
Figure 1 Radiological images at the time of diagnosis. A: Abdominal magnetic resonance imaging showed a hypovascular mass present in the tail of the pancreas 6.4 cm × 4.2 cm in size; B: Multiple hypovascular nodules of no more than 7.1 cm × 5.5 cm scattered in the liver parenchyma; C: Colonoscopy image showing a 2.2 cm × 1.6 cm mass with surface congestive erosions, which was 33 cm from the anus.
Figure 2
Figure 2 Results of pathologic diagnosis. A: Fine-needle aspiration biopsy of the left lobe of the liver; B: Biopsy from colonoscopy. Magnification: 40 ×; scale bar: 100 μm.
Figure 3
Figure 3 Histopathological analysis of biopsy from the colon lesion. A: CK 7 positive; B: CK positive; C: CK 20 negative; D: CDX2 negative; E: SATB2 negative. Magnification: 10 ×.
Figure 4
Figure 4 Radiological images of response assessment to FOLFIRINOX treatment. A: Abdominal magnetic resonance imaging after 12 cycles of FOLFIRINOX treatment showing the size of the hypovascular mass in the tail of the pancreas had shrunk to 4.2 cm × 2.0 cm; B: Multiple hypovascular nodules in the liver parenchyma were also reduced to less than 3.5 cm; C: A colonoscopy after 9 cycles of FOLFIRINOX showing that the mucosa of the original lesion site was slightly rough and red, and that no protuberant or new mucosal lesions were found.


Write to the Help Desk